Switch to:
Also traded in: Germany, UK, USA

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.06
SNN's Cash-to-Debt is ranked lower than
95% of the 325 Companies
in the Global Medical Devices industry.

( Industry Median: 2.55 vs. SNN: 0.06 )
Ranked among companies with meaningful Cash-to-Debt only.
SNN' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.06  Med: 0.17 Max: 2.58
Current: 0.06
0.06
2.58
Equity-to-Asset 0.54
SNN's Equity-to-Asset is ranked lower than
63% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. SNN: 0.54 )
Ranked among companies with meaningful Equity-to-Asset only.
SNN' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.34  Med: 0.54 Max: 0.7
Current: 0.54
0.34
0.7
Interest Coverage 13.57
SNN's Interest Coverage is ranked lower than
70% of the 222 Companies
in the Global Medical Devices industry.

( Industry Median: 86.37 vs. SNN: 13.57 )
Ranked among companies with meaningful Interest Coverage only.
SNN' s Interest Coverage Range Over the Past 10 Years
Min: 8.87  Med: 16.93 Max: 94
Current: 13.57
8.87
94
Piotroski F-Score: 7
Altman Z-Score: 4.79
Beneish M-Score: -2.46
WACC vs ROIC
4.04%
11.26%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 17.27
SNN's Operating Margin % is ranked higher than
85% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 2.62 vs. SNN: 17.27 )
Ranked among companies with meaningful Operating Margin % only.
SNN' s Operating Margin % Range Over the Past 10 Years
Min: 13.55  Med: 17.89 Max: 23.22
Current: 17.27
13.55
23.22
Net Margin % 17.21
SNN's Net Margin % is ranked higher than
88% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 1.55 vs. SNN: 17.21 )
Ranked among companies with meaningful Net Margin % only.
SNN' s Net Margin % Range Over the Past 10 Years
Min: 8.85  Med: 12.65 Max: 17.43
Current: 17.21
8.85
17.43
ROE % 21.10
SNN's ROE % is ranked higher than
90% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 1.31 vs. SNN: 21.10 )
Ranked among companies with meaningful ROE % only.
SNN' s ROE % Range Over the Past 10 Years
Min: 10.47  Med: 19.69 Max: 25.27
Current: 21.1
10.47
25.27
ROA % 11.37
SNN's ROA % is ranked higher than
88% of the 327 Companies
in the Global Medical Devices industry.

( Industry Median: 0.06 vs. SNN: 11.37 )
Ranked among companies with meaningful ROA % only.
SNN' s ROA % Range Over the Past 10 Years
Min: 5.79  Med: 9.82 Max: 13.65
Current: 11.37
5.79
13.65
ROC (Joel Greenblatt) % 56.87
SNN's ROC (Joel Greenblatt) % is ranked higher than
89% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 4.26 vs. SNN: 56.87 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
SNN' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 30.86  Med: 43.35 Max: 58.88
Current: 56.87
30.86
58.88
3-Year Revenue Growth Rate 12.60
SNN's 3-Year Revenue Growth Rate is ranked higher than
74% of the 237 Companies
in the Global Medical Devices industry.

( Industry Median: 4.40 vs. SNN: 12.60 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
SNN' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -17.8  Med: 9.6 Max: 37.9
Current: 12.6
-17.8
37.9
3-Year EBITDA Growth Rate 21.30
SNN's 3-Year EBITDA Growth Rate is ranked higher than
71% of the 208 Companies
in the Global Medical Devices industry.

( Industry Median: 5.10 vs. SNN: 21.30 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
SNN' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -14.6  Med: 11.8 Max: 41.9
Current: 21.3
-14.6
41.9
3-Year EPS without NRI Growth Rate 23.40
SNN's 3-Year EPS without NRI Growth Rate is ranked higher than
77% of the 203 Companies
in the Global Medical Devices industry.

( Industry Median: 1.40 vs. SNN: 23.40 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
SNN' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -15  Med: 15.8 Max: 44.2
Current: 23.4
-15
44.2
GuruFocus has detected 4 Warning Signs with Smith & Nephew PLC $SNN.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» SNN's 30-Y Financials

Financials (Next Earnings Date: 2017-07-27)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2016

SNN Guru Trades in Q2 2016

Ken Fisher 2,420,956 sh (+0.15%)
Mario Gabelli Sold Out
Jim Simons 850,300 sh (-23.50%)
» More
Q3 2016

SNN Guru Trades in Q3 2016

Ken Fisher 2,479,137 sh (+2.40%)
Jim Simons 764,900 sh (-10.04%)
» More
Q4 2016

SNN Guru Trades in Q4 2016

Steven Cohen 236,800 sh (New)
Ken Fisher 2,404,292 sh (-3.02%)
Jim Simons 701,250 sh (-8.32%)
» More
Q1 2017

SNN Guru Trades in Q1 2017

Steven Cohen 358,700 sh (+51.48%)
Jim Simons 734,000 sh (+4.67%)
Ken Fisher 2,255,298 sh (-6.20%)
» More
» Details

Insider Trades

Latest Guru Trades with SNN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 339113 
Compare:NAS:ALGN, OTCPK:SONVY, NYSE:TFX, NYSE:VAR, NYSE:STJ, OTCPK:CNVVY, NYSE:EW, NYSE:ZBH, OTCPK:WILYY, OTCPK:CHEOY, NAS:ABMD, NAS:MASI, OTCPK:FSPKF, OTCPK:GGNDF, OTCPK:EKTAY, NAS:NUVA, NAS:IART, NYSE:GMED, OTCPK:AMBFF, NYSE:PEN » details
Traded in other countries:NPWA.Germany, SN..UK, SNNUF.USA,
Headquarter Location:UK
Smith & Nephew PLC develops, manufactures, markets and sells medical devices. Its segments include Advanced Surgical Devices and Advanced Wound Management.

Smith & Nephew designs, manufactures, and markets orthopedic devices and wound-care solutions. Approximately three fourths of the U.K.-based firm's revenue comes from knee replacements, hip implants, nails, fixation devices, and arthroscopy tools. The remaining 25% of revenue is from the wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from developed European and Asian markets, 40% is from the United States, and emerging markets account for the remainder.

Ratios

vs
industry
vs
history
PE Ratio 19.87
SNN's PE Ratio is ranked higher than
72% of the 177 Companies
in the Global Medical Devices industry.

( Industry Median: 27.53 vs. SNN: 19.87 )
Ranked among companies with meaningful PE Ratio only.
SNN' s PE Ratio Range Over the Past 10 Years
Min: 12  Med: 17.57 Max: 43.01
Current: 19.87
12
43.01
Forward PE Ratio 19.23
SNN's Forward PE Ratio is ranked higher than
79% of the 111 Companies
in the Global Medical Devices industry.

( Industry Median: 21.79 vs. SNN: 19.23 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 19.87
SNN's PE Ratio without NRI is ranked higher than
71% of the 175 Companies
in the Global Medical Devices industry.

( Industry Median: 27.51 vs. SNN: 19.87 )
Ranked among companies with meaningful PE Ratio without NRI only.
SNN' s PE Ratio without NRI Range Over the Past 10 Years
Min: 12.38  Med: 20.12 Max: 43.01
Current: 19.87
12.38
43.01
Price-to-Owner-Earnings 17.80
SNN's Price-to-Owner-Earnings is ranked higher than
80% of the 107 Companies
in the Global Medical Devices industry.

( Industry Median: 32.96 vs. SNN: 17.80 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
SNN' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 11.57  Med: 16.32 Max: 47.82
Current: 17.8
11.57
47.82
PB Ratio 3.85
SNN's PB Ratio is ranked lower than
55% of the 298 Companies
in the Global Medical Devices industry.

( Industry Median: 3.11 vs. SNN: 3.85 )
Ranked among companies with meaningful PB Ratio only.
SNN' s PB Ratio Range Over the Past 10 Years
Min: 2.63  Med: 3.86 Max: 7.01
Current: 3.85
2.63
7.01
PS Ratio 3.23
SNN's PS Ratio is ranked higher than
54% of the 296 Companies
in the Global Medical Devices industry.

( Industry Median: 3.20 vs. SNN: 3.23 )
Ranked among companies with meaningful PS Ratio only.
SNN' s PS Ratio Range Over the Past 10 Years
Min: 1.44  Med: 2.87 Max: 4.33
Current: 3.23
1.44
4.33
Price-to-Free-Cash-Flow 32.95
SNN's Price-to-Free-Cash-Flow is ranked lower than
51% of the 112 Companies
in the Global Medical Devices industry.

( Industry Median: 27.61 vs. SNN: 32.95 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
SNN' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 14.01  Med: 24.18 Max: 85.26
Current: 32.95
14.01
85.26
Price-to-Operating-Cash-Flow 17.73
SNN's Price-to-Operating-Cash-Flow is ranked higher than
58% of the 140 Companies
in the Global Medical Devices industry.

( Industry Median: 20.26 vs. SNN: 17.73 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
SNN' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 8.87  Med: 14.64 Max: 32.24
Current: 17.73
8.87
32.24
EV-to-EBIT 15.57
SNN's EV-to-EBIT is ranked higher than
78% of the 275 Companies
in the Global Medical Devices industry.

( Industry Median: 24.54 vs. SNN: 15.57 )
Ranked among companies with meaningful EV-to-EBIT only.
SNN' s EV-to-EBIT Range Over the Past 10 Years
Min: 8.8  Med: 14.55 Max: 30.7
Current: 15.57
8.8
30.7
EV-to-EBITDA 11.08
SNN's EV-to-EBITDA is ranked higher than
80% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 19.31 vs. SNN: 11.08 )
Ranked among companies with meaningful EV-to-EBITDA only.
SNN' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.8  Med: 10.3 Max: 19
Current: 11.08
6.8
19
PEG Ratio 2.82
SNN's PEG Ratio is ranked lower than
52% of the 83 Companies
in the Global Medical Devices industry.

( Industry Median: 2.52 vs. SNN: 2.82 )
Ranked among companies with meaningful PEG Ratio only.
SNN' s PEG Ratio Range Over the Past 10 Years
Min: 0.42  Med: 0.97 Max: 13.95
Current: 2.82
0.42
13.95
Shiller PE Ratio 32.62
SNN's Shiller PE Ratio is ranked higher than
76% of the 50 Companies
in the Global Medical Devices industry.

( Industry Median: 49.41 vs. SNN: 32.62 )
Ranked among companies with meaningful Shiller PE Ratio only.
SNN' s Shiller PE Ratio Range Over the Past 10 Years
Min: 21.48  Med: 29.43 Max: 36.81
Current: 32.62
21.48
36.81
Current Ratio 1.88
SNN's Current Ratio is ranked lower than
65% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 2.38 vs. SNN: 1.88 )
Ranked among companies with meaningful Current Ratio only.
SNN' s Current Ratio Range Over the Past 10 Years
Min: 0.84  Med: 1.84 Max: 2.42
Current: 1.88
0.84
2.42
Quick Ratio 0.95
SNN's Quick Ratio is ranked lower than
81% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 1.79 vs. SNN: 0.95 )
Ranked among companies with meaningful Quick Ratio only.
SNN' s Quick Ratio Range Over the Past 10 Years
Min: 0.47  Med: 0.95 Max: 1.35
Current: 0.95
0.47
1.35
Days Inventory 345.38
SNN's Days Inventory is ranked lower than
90% of the 289 Companies
in the Global Medical Devices industry.

( Industry Median: 130.04 vs. SNN: 345.38 )
Ranked among companies with meaningful Days Inventory only.
SNN' s Days Inventory Range Over the Past 10 Years
Min: 253.48  Med: 320.35 Max: 374.7
Current: 345.38
253.48
374.7
Days Sales Outstanding 82.20
SNN's Days Sales Outstanding is ranked lower than
63% of the 272 Companies
in the Global Medical Devices industry.

( Industry Median: 68.94 vs. SNN: 82.20 )
Ranked among companies with meaningful Days Sales Outstanding only.
SNN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 73.96  Med: 81.43 Max: 94.34
Current: 82.2
73.96
94.34

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 1.77
SNN's Dividend Yield % is ranked higher than
63% of the 191 Companies
in the Global Medical Devices industry.

( Industry Median: 1.33 vs. SNN: 1.77 )
Ranked among companies with meaningful Dividend Yield % only.
SNN' s Dividend Yield % Range Over the Past 10 Years
Min: 0.83  Med: 1.59 Max: 2.3
Current: 1.77
0.83
2.3
Dividend Payout Ratio 0.36
SNN's Dividend Payout Ratio is ranked higher than
57% of the 122 Companies
in the Global Medical Devices industry.

( Industry Median: 0.40 vs. SNN: 0.36 )
Ranked among companies with meaningful Dividend Payout Ratio only.
SNN' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.22  Med: 0.31 Max: 0.68
Current: 0.36
0.22
0.68
3-Year Dividend Growth Rate 16.30
SNN's 3-Year Dividend Growth Rate is ranked higher than
67% of the 81 Companies
in the Global Medical Devices industry.

( Industry Median: 8.00 vs. SNN: 16.30 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
SNN' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: -54  Med: 12.65 Max: 19.6
Current: 16.3
-54
19.6
Forward Dividend Yield % 2.12
SNN's Forward Dividend Yield % is ranked higher than
70% of the 183 Companies
in the Global Medical Devices industry.

( Industry Median: 1.67 vs. SNN: 2.12 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 3.70
SNN's 5-Year Yield-on-Cost % is ranked higher than
83% of the 219 Companies
in the Global Medical Devices industry.

( Industry Median: 1.97 vs. SNN: 3.70 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
SNN' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.74  Med: 3.33 Max: 4.81
Current: 3.7
1.74
4.81
3-Year Average Share Buyback Ratio -0.40
SNN's 3-Year Average Share Buyback Ratio is ranked higher than
76% of the 218 Companies
in the Global Medical Devices industry.

( Industry Median: -3.90 vs. SNN: -0.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
SNN' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -2.5  Med: -0.15 Max: 20.2
Current: -0.4
-2.5
20.2

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 42.48
SNN's Price-to-Tangible-Book is ranked lower than
95% of the 263 Companies
in the Global Medical Devices industry.

( Industry Median: 4.11 vs. SNN: 42.48 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
SNN' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 4.86  Med: 17.51 Max: 66.37
Current: 42.48
4.86
66.37
Price-to-Intrinsic-Value-Projected-FCF 1.88
SNN's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
66% of the 129 Companies
in the Global Medical Devices industry.

( Industry Median: 2.23 vs. SNN: 1.88 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
SNN' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 1.09  Med: 2.02 Max: 5.92
Current: 1.88
1.09
5.92
Price-to-Intrinsic-Value-DCF (Earnings Based) 1.45
SNN's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked higher than
80% of the 25 Companies
in the Global Medical Devices industry.

( Industry Median: 1.82 vs. SNN: 1.45 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 1.13
SNN's Price-to-Median-PS-Value is ranked higher than
53% of the 242 Companies
in the Global Medical Devices industry.

( Industry Median: 1.03 vs. SNN: 1.13 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
SNN' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.53  Med: 1.2 Max: 2.71
Current: 1.13
0.53
2.71
Price-to-Peter-Lynch-Fair-Value 2.84
SNN's Price-to-Peter-Lynch-Fair-Value is ranked lower than
68% of the 57 Companies
in the Global Medical Devices industry.

( Industry Median: 1.61 vs. SNN: 2.84 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
SNN' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.62  Med: 1.22 Max: 5.94
Current: 2.84
0.62
5.94
Price-to-Graham-Number 6.03
SNN's Price-to-Graham-Number is ranked lower than
82% of the 138 Companies
in the Global Medical Devices industry.

( Industry Median: 2.19 vs. SNN: 6.03 )
Ranked among companies with meaningful Price-to-Graham-Number only.
SNN' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.94  Med: 5.42 Max: 9.9
Current: 6.03
1.94
9.9
Earnings Yield (Greenblatt) % 6.42
SNN's Earnings Yield (Greenblatt) % is ranked higher than
86% of the 432 Companies
in the Global Medical Devices industry.

( Industry Median: 2.17 vs. SNN: 6.42 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
SNN' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 3.3  Med: 6.9 Max: 11.4
Current: 6.42
3.3
11.4
Forward Rate of Return (Yacktman) % 9.60
SNN's Forward Rate of Return (Yacktman) % is ranked higher than
52% of the 125 Companies
in the Global Medical Devices industry.

( Industry Median: 8.85 vs. SNN: 9.60 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
SNN' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 1  Med: 21.6 Max: 36.1
Current: 9.6
1
36.1

More Statistics

Revenue (TTM) (Mil) $4,669
EPS (TTM) $ 1.76
Beta0.57
Short Percentage of Float0.00%
52-Week Range $26.97 - 35.30
Shares Outstanding (Mil)451.86

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 4,849 5,026 5,198
EPS ($) 1.82 2.02 2.10
EPS without NRI ($) 1.82 2.02 2.10
EPS Growth Rate
(Future 3Y To 5Y Estimate)
18.20%
Dividends per Share ($) 0.64 0.68 0.77
» More Articles for SNN

Headlines

Articles On GuruFocus.com
Collagenase SANTYL® Ointment advances pressure ulcers through the healing process faster, new study May 04 2017 
Invesco European Growth Fund Adds to More Than 40 Existing Stakes Apr 04 2016 
Invesco European Growth Fund Adds to 7 Stakes Jan 26 2016 
Sintana Energy Reports Manati Blanco-1 Well Drilling Progress-To-Date and Provides Operations Update Aug 04 2015 
Edwards Lifesciences a Gold Standard in the Market Dec 16 2014 
Sintana Energy Reports on Execution of Drilling Rig Contract Dec 11 2014 
3 Dividend Kings From The U.K. I Love To Buy Aug 21 2014 
Stryker Corporation (SYK) Dividend Stock Analysis Jan 11 2013 
5 Highly Predictable Mid-/Large-Caps with ROC Over 15% Apr 21 2012 
The Best Dividends on April 18, 2012 Apr 18 2012 

More From Other Websites
Electrical Stimulation Therapy and E-Qure - A Potential 20x in 18 Months or Less May 25 2017
Study results demonstrate 74% reduction in surgical site infections with use of PICO™ Single use... May 16 2017
Smith & Nephew says M&A 'not at top of agenda' at the moment May 05 2017
Medical Product Stocks Q1 Earnings Slated on May 5: VWR, SNN May 04 2017
Collagenase SANTYL® Ointment advances pressure ulcers through the healing process faster, new study... May 04 2017
ETFs with exposure to Smith & Nephew Plc : April 27, 2017 Apr 27 2017
Smith & Nephew Plc : SNN-US: Dividend Analysis : March 31st, 2017 (record date) : By the numbers :... Apr 11 2017
International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual... Mar 16 2017
Smith & Nephew previews NAVIO™ Robotics-assisted Total Knee Application at AAOS ahead of full... Mar 14 2017
Smith & Nephew Plc :SNN-US: Earnings Analysis: For the six months ended December 31, 2016 : March 6,... Mar 06 2017
Smith & Nephew invests in and signs agreement to distribute disruptive Leaf Healthcare pressure... Feb 22 2017
These drug and medical device companies made the most payments to N.Y.C. hospitals Feb 14 2017
Smith & Nephew Plc :SNN-US: Earnings Analysis: 2016 By the Numbers : February 10, 2017 Feb 10 2017
Smith & Nephew hurt by tough markets in China and Gulf states Feb 09 2017
Mass. lawmakers join effort to put a stake through the heart of the medical device tax Jan 24 2017
ETFs with exposure to Smith & Nephew Plc : January 11, 2017 Jan 11 2017
Smith & Nephew wins prestigious Galien Award for PICO Negative Pressure Wound Therapy innovation Dec 21 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)